256 related articles for article (PubMed ID: 10821970)
1. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.
Markoff L
Vaccine; 2000 May; 18 Suppl 2():26-32. PubMed ID: 10821970
[TBL] [Abstract][Full Text] [Related]
2. Safety, immunogenicity, and protective efficacy of NYVAC-JEV and ALVAC-JEV recombinant Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):343-9. PubMed ID: 10466959
[TBL] [Abstract][Full Text] [Related]
3. An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):329-37. PubMed ID: 10466957
[TBL] [Abstract][Full Text] [Related]
4. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
5. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
6. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
7. Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.
Pan JR; Yan JY; Zhou JY; Tang XW; He HQ; Xie RH; Mao HY; Zhang YJ; Xie SY
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004936. PubMed ID: 27560360
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
[TBL] [Abstract][Full Text] [Related]
9. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
[TBL] [Abstract][Full Text] [Related]
10. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
11. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.
Kanesa-thasan N; Smucny JJ; Hoke CH; Marks DH; Konishi E; Kurane I; Tang DB; Vaughn DW; Mason PW; Shope RE
Vaccine; 2000 Oct; 19(4-5):483-91. PubMed ID: 11027812
[TBL] [Abstract][Full Text] [Related]
13. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
Appaiahgari MB; Vrati S
Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice.
Li J; Chen H; Wu N; Fan D; Liang G; Gao N; An J
Vaccine; 2013 Aug; 31(38):4136-42. PubMed ID: 23845821
[TBL] [Abstract][Full Text] [Related]
15. Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity.
Fan Y-C; Chen J-M; Chen Y-Y; Ke Y-D; Chang G-JJ; Chiou S-S
J Virol; 2024 Apr; 98(4):e0177323. PubMed ID: 38530012
[TBL] [Abstract][Full Text] [Related]
16. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
17. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Immune Responses Against Japanese Encephalitis Virus Infection Using Japanese Encephalitis Live-Attenuated Virus Adjuvanted with Montanide GEL 01 ST in Mice.
Xu Y; Wang Q; Wei B; Huang X; Wen Y; Yan Q; Ma X; Zhao Q; Cao S; Huang Y; Wen X; Han X; Bai Y; Wu R
Vector Borne Zoonotic Dis; 2019 Nov; 19(11):835-843. PubMed ID: 31314706
[TBL] [Abstract][Full Text] [Related]
20. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
